Strut Health / Rosacea Formula
The offering lists azelaic acid, oxymetazoline, metronidazole and ivermectin as possible ingredients. That is a menu for a clinician, not proof that all four arrive in one cream or that all rosacea symptoms need the same treatment.
There is a real reason to hesitate. Read the finding before you buy.
ASSESSED ON 15% OF THE MODEL. 5 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
The provider should identify the symptoms being treated and the exact composition of your cream.
Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.
BROWSE COREAGE RX SKINCAREREAD OUR REVIEWThe verdict
The product-specific wording says formulas may contain a combination of the listed ingredients. Preserving that qualification matters. A review should not turn a range of options into a single fixed four-drug product.
Price and mass are stated, but the page also contains unrelated eye and neck content and does not establish the patient's ingredient concentrations. Verify the actual prescription and treatment target before agreeing to recurring delivery.
- Describes ingredients as possibilities rather than promising every patient all four.
- Publishes a price and 25 g quantity.
- Acknowledges that the selected formula depends on the presentation of rosacea.
- The individual combination and concentrations require confirmation.
- Unrelated product sections are present on the retrieved page.
- A single sales category can obscure the difference between redness and inflammatory lesions.
Every active, assessed
- Azelaic acidCONFIRM ON INDIVIDUAL PRESCRIPTION
Possible ingredient for inflammatory lesions
- BENCHMARK
- Exact concentration and vehicle required for comparison
- ASSESSMENT
- An ingredient name is recorded here without assigning a concentration from another product or a different section of the website.
- OxymetazolineCONFIRM ON INDIVIDUAL PRESCRIPTION
Possible ingredient for persistent facial redness
- BENCHMARK
- Exact concentration and vehicle required for comparison
- ASSESSMENT
- An ingredient name is recorded here without assigning a concentration from another product or a different section of the website.
- MetronidazoleCONFIRM ON INDIVIDUAL PRESCRIPTION
Possible rosacea treatment ingredient
- BENCHMARK
- Exact concentration and vehicle required for comparison
- ASSESSMENT
- An ingredient name is recorded here without assigning a concentration from another product or a different section of the website.
- IvermectinCONFIRM ON INDIVIDUAL PRESCRIPTION
Possible ingredient for inflammatory lesions
- BENCHMARK
- Exact concentration and vehicle required for comparison
- ASSESSMENT
- An ingredient name is recorded here without assigning a concentration from another product or a different section of the website.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| Azelaic acidPossible ingredient for inflammatory lesions | CONFIRM ON INDIVIDUAL PRESCRIPTION | Exact concentration and vehicle required for comparison | An ingredient name is recorded here without assigning a concentration from another product or a different section of the website. |
| OxymetazolinePossible ingredient for persistent facial redness | CONFIRM ON INDIVIDUAL PRESCRIPTION | Exact concentration and vehicle required for comparison | An ingredient name is recorded here without assigning a concentration from another product or a different section of the website. |
| MetronidazolePossible rosacea treatment ingredient | CONFIRM ON INDIVIDUAL PRESCRIPTION | Exact concentration and vehicle required for comparison | An ingredient name is recorded here without assigning a concentration from another product or a different section of the website. |
| IvermectinPossible ingredient for inflammatory lesions | CONFIRM ON INDIVIDUAL PRESCRIPTION | Exact concentration and vehicle required for comparison | An ingredient name is recorded here without assigning a concentration from another product or a different section of the website. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%NOT ASSESSED
Ingredient background is discussed separately. No performance score is assigned to an untested service or to a prescription that varies by patient.
- FORMULATION INTEGRITYWEIGHT 20%NOT ASSESSED
The exact dispensed preparation, manufacturer or patient-specific base was not inspected.
- DISCLOSUREWEIGHT 15%45/100
The menu qualification, price and mass are useful. Unrelated formula sections and absence of a verified individual composition limit disclosure confidence.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
No patient panel or personal treatment course. Cannot infer tolerability from ingredient names or testimonials.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
No product-in-hand testing.
- COST PER APPLICATIONWEIGHT 10%NOT ASSESSED
Published fees are compared in the text. Actual dispensed quantity, application amount and usable duration are needed for this criterion.
Open the review comparison tray →
The symptom is part of the prescription
Rosacea treatment is selected for the features present. The American Academy of Dermatology distinguishes persistent facial redness from inflammatory acne-like bumps and from eye involvement. A page titled rosacea cannot, on its own, settle which of those needs treatment. The consultation should supply that missing specificity.
Why the ingredient menu matters
The Strut product description lists azelaic acid, oxymetazoline, metronidazole and ivermectin as possible ingredients. This review records them as options, not as a verified recipe. Ask which ingredients the proposed cream contains, what each is intended to do and what will be reassessed if one symptom improves while another does not.
Oxymetazoline's role in persistent redness should not be confused with the role of treatments aimed at inflammatory bumps. Combining treatments can be a clinician's decision, but the number of ingredients does not demonstrate a superior result. Our ingredient and product reference pages can help make that conversation more specific.
The manufactured oxymetazoline redness treatment.
An ivermectin product assessed for inflammatory lesions.
Another compounded route with a different public ingredient list.
What the quantity tells us
The listed $59 for 25 g works out to $2.36 per gram. That is an arithmetic comparison of the published offer, not a cost per application or monthly guarantee. Confirm the refill interval, actual amount prescribed and usable life of the dispensed cream before setting it beside another product's recurring price.
The page still needs reconciliation
The retrieved page contains sections describing unrelated eye and neck formulas. We exclude their ingredients and result timelines. A clear individual label can resolve what a patient receives, but the public page still makes pre-purchase assessment harder than necessary. Our caution is about that documentation problem; no batch testing or clinical service testing was performed.
Who this is for
- Someone with diagnosed rosacea whose clinician gives a clear reason for a particular combination.
- You are treating undiagnosed redness or an unexplained rash.
- You have eye pain or vision changes; seek appropriate medical assessment.
- You cannot get a consistent ingredient list for the prescribed product.
The provider should identify the symptoms being treated and the exact composition of your cream.
Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.
BROWSE COREAGE RX SKINCAREREAD OUR REVIEWThis is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01Strut Health — Rosacea Formula $59 for 25 g and a menu of possible ingredients, not a guarantee of all four in one formula. Unrelated eye/neck sections are excluded. Checked 13 September 2026.
- S-02American Academy of Dermatology — rosacea treatment Different treatment targets for persistent redness, inflammatory bumps and eye involvement. Evidence for individual treatments does not establish a compounded combination's performance. Checked 13 September 2026.
- S-03FDA — understanding compounded-drug risks Compounded preparations do not undergo FDA premarket review for safety, effectiveness or quality; they can meet individual medical needs. Checked 13 September 2026.